Home|Journals|Articles by Year|Audio Abstracts

Review Article

AAM. 2022; 11(4): 339-348

Pramehahara Yoga (Anti-diabetic formulations) – A Laghutrayi review

Amulya Kannan,Raghavendra Naik,Vrinda,Shilpashree A T,Kavya N,Sulochana Bhat.


Background: Diabetes is a major non-communicable disease reaching epidemic proportions. Inspite of vigorous development in modern medical science and technology, management of diabetes has remained inadequate. Ayurveda with vast documentation of treatment in management of Prameha may hold the key to this problem. Aim: This review is expected to enrich the documentary evidences about classical references on formulations related to Prameha (Diabetes mellitus) enumerated in Laghutrayi. Material and methods: Laghutrayi texts are considered as one among the best Ayurveda treatises for understanding treatment principles of any disease. A total of 117 Pramehahara (anti-diabetic) formulations have been compiled from Laghutrayi by searching specific keywords from individual text’s hardcopy. Key words searched in phalashruti (verse with indications) included “prameha”, “meha”, “madhumeha” with suffixes like “hanti”, “harati”, “jayati”, “jit”, “nihanti”, “nashayet”, “nivrittaye”, “ghna”. Results: kvatha (decoction) is the highest enumerated dosage form (55 formulations) in Laghutrayi. Honey is the most enumerated adjuvant in Laghutrayi. Triphala is the highest enumerated herbal formulation in Laghutrayi (18 formulations), followed by Daruharidra (12 formulations). Conclusion: Validating these comprehensive observations of Pramehahara yoga (anti-diabetic formulations) mentioned in Laghutrayi may facilitate a better and precise treatment protocol in management of Diabetes mellitus.

Key words: Ayurveda, Prameha, Diabetes mellitus, Antidiabetic formulations, Laghutrayi

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.